About Opella
Opella is a company based in Neuilly-sur-seine (France) founded in 2019 was acquired by CD&R in October 2024. Opella offers products and services including OTC Products, VMS Products, and Self-Care Brands. Opella operates in a competitive market with competitors including Cardinal Health, ACG Associated Capsules, Dvijay Pharma, Nu Sri Shyam Pharmaceuticals and Kapbro Pharma, among others.
- Headquarter Neuilly-sur-seine, France
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Website opella.com/en
- Social LinkedIn
- Acquired by CD&R (Oct 2024)
- Legal Name Opella Oü
Products & Services of Opella
Opella offers a comprehensive portfolio of products and services, including OTC Products, VMS Products, and Self-Care Brands.
Over-the-counter items for everyday self-care and health needs
Vitamins and minerals supporting daily wellness and nutrition
Branded solutions for simple health management and prevention
Investors in Opella
Opella has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include CD&R.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
A private equity firm focused on building long-term business value. | – | cdr.com | New York, United States |
Investor details for Opella
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Opella
1 people are tracked at Opella (1 in leadership).
| Name | Role | Group |
|---|---|---|
Julie Van Ongevalle | CEO & President | Leadership |
Complete people profiles for Opella
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Opella
2 dated milestones of Opella across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Opella is founded.
- Exit Acquired by CD&R.
Competitors of Opella
Opella operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cardinal Health, ACG Associated Capsules, Dvijay Pharma, Nu Sri Shyam Pharmaceuticals and Kapbro Pharma, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| cardinalhealth.com | 1971 | Dublin, United States | – | 48,900 | Multiple healthcare products and services are provided to organizations. | |
| associatedcapsules.com | 1961 | Mumbai, India | – | 1,444 | A distributor specializing in gelatin capsules for pharmaceutical applications. | |
| dvijaypharma.com | 1975 | Nashik, India | – | 68 | Serves as a distributor of specialty drugs. | |
| nsspharma.com | 2013 | Kolkata, India | – | 58 | Distributes anti-HIV, life-saving, and anti-cancer medicines to hospitals and patients. | |
| kapbropharma.com | 2018 | Delhi, India | – | 26 | Distributes super-speciality and general pharmaceuticals to chemists, hospitals, and patients. | |
| shivshivampharma.com | 1989 | Kolkata, India | – | 18 | Distributor and retailer of oncology medicines with partnerships in healthcare. | |
| shreejiimaging.com | 1990 | Mumbai, India | – | – | Manufactures PET radiotracers for cancer detection and disease management. |
Detailed competitors of Opella
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Opella
The website of Opella (opella.com) receives about 78.4K visits a month and ranks #531,814 among all websites worldwide, #549 in Biotechnology and Pharmaceuticals.
- Monthly visits78.4K
▲ 11% vs previous month
- Unique visitors31.1K
per month
- Global rank#531,814
among all websites
- Category rank#549
Health · Biotechnology and Pharmaceuticals
- Bounce rate45%
- Pages per visit1.8
- Average visit33 sec
- DevicesDesktop 34% · Mobile 66%
Websites whose visitors overlap most with Opella. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
ehub-healthcare.com | ehub-healthcare.com | 100% | – | #2,739,091 | – |
| iqviabiotech.com | 90% | – | #2,558,852 | View details | |
sanofi.fr | sanofi.fr | 82% | – | #671,083 | – |
| renuebyscience.com | 54% | 93.8K | #514,903 | View details | |
| draeger.com | 51% | 506.6K | #88,969 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 13 similar websites and full traffic analytics for Opella
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 13 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Opella
Complete news archive for Opella
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Opella
10 companies that operate in the same segment as Opella (Traditional Health & Nutrition), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Manufacturer of generics formulations | 2002 | Bridgewater, New Jersey, United States | – | USD 3.02 B | 8,300 | |
Biosimilar therapeutics are developed for oncology and autoimmune diseases. | 2010 | Redwood City, California, United States | USD 143.62 M | USD 42.17 M | 228 | |
Oral solid drug delivery systems are manufactured and developed. | 1985 | Mumbai, Maharashtra, India | USD 42.49 M | USD 89.42 M | 962 | |
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | Bridgewater, New Jersey, United States | – | USD 5.1 B | 13,500 | |
Generic pharmaceuticals are manufactured by Teva Pharmaceuticals. | 1901 | Petah Tikva, Central District, Israel | USD 500 M | USD 18.74 B | 51,792 | |
Generic, semi-solid, and liquid dosage forms are manufactured. | 1990 | Bengaluru, Karnataka, India | – | USD 508.93 M | 5,180 | |
Pharmaceutical products are developed and marketed globally. | 2009 | Montville, New Jersey, United States | USD 155.92 M | – | – | |
Specialty generic pharmaceuticals and APIs are manufactured and marketed. | 1983 | Mumbai, Maharashtra, India | – | USD 6.21 B | 25,870 | |
Pharmaceutical company engaged in developing, manufacturing, and marketing a diverse range of pharmaceutical formulations | 1991 | Delhi, Delhi, India | USD 367.2 M | USD 1.52 B | 21,320 | |
Generics, biosimilars, APIs, and vaccines are manufactured by Wockhardt. | 1967 | Mumbai, Maharashtra, India | – | USD 353.53 M | 3,410 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Opella
Opella was founded in 2019.
Opella is headquartered in Neuilly-sur-seine, France. It is registered at Neuilly-sur-seine, Hauts-de-seine, France.
Julie Van Ongevalle is the current CEO of Opella.
Annual revenue of Opella is $27.35K as on Dec 31, 2023.
Opella was founded in 2019 as a distributor in the over-the-counter medicines, vitamins, minerals, and supplements sector. Operations focus on a global portfolio that includes well-known brands such as Allegra, Buscopan, Doliprane, Dulcolax, Enterogermina, Essentiale, and Mucosolvan. Leadership is provided by CEO and President Julie Van Ongevalle, with activities centered on product distribution and manufacturing support across international markets.
Opella's top competitors include Cardinal Health, Dvijay Pharma and ACG Associated Capsules.
Opella offers OTC Products, VMS Products, and Self-Care Brands.
Opella has 1 investor. Key investors include CD&R.
Opella operates through Opella Oü.
Yes. Opella was acquired by CD&R in October 2024.